L-Alanyl-L-Glutamine

Product Details

CAS No:39537-23-0

MF:C8H15N3O4

Appearance:white or off-white crystalline powder

Specification:98.5%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Product application:L-Alanyl-L-Glutamine, Ala-Gln, CAS 39537-23-0, Alanyl Glutamine, Parenteral Nutrition, Cell Culture Supplement, Pharmaceutical Grade Amino Acid, Stable Glutamine Dipeptide, Bio-pharmaceutical Raw Material, Glutamine Source, Clinical Nutritional Support, Immune-enhancing Agent, Peptide Synthesis, Protein Metabolism Support, High Purity Dipeptide, Water-soluble Amino Acid, Cell Culture Media Additive, API for Nutrition, Parenteral Infusion Ingredient.

Synonyms:Alanyl-glutamine; Ala-Gln; Glutamine-S; N(2)-l-alanyl-l-glutamine; L-Alanyl-L-glutamine(Ala-Gln);L-ALANINE-L-GLUTAMINE;L-ALANYL-L-GLUTAMINE;H-ALA-GLN-OH;glutamine-s;DIPEPTIVEN;ALANYL-GLUTAMINE;ALA-GLN,L-Alanyl-L-Glutamine,"l-Alanyl-l-glutamine; 39537-23-0; Ala-gln; alanylglutamine; alanyl glutamine; Dipeptamin; GlutaMAX; Sustamine; N(2)-L-Alanyl-L-glutamine; Alanyl-glutamine dipeptide; L-Glutamine, N2-L-alanyl-; U5JDO2770Z; L-alanyl-l-glutamine amino acid; FEMA NO. 4712; CHEBI:73788; DTXSID20192658; (2S)-5-amino-2-(((2S)-2-azaniumylpropanoyl)amino)-5-oxopentanoate; (2S)-5-amino-2-{[(2S)-2-azaniumylpropanoyl]amino}-5-oxopentanoate; L-alanyl/L-glutamine; DTXCID60115149; 609-717-9; Alanyl-glutamine; H-Ala-Gln-OH; L-Ala-L-Gln; MFCD00133046; L-Glutamine, L-alanyl-; Dipeptiven; (S)-5-amino-2-((S)-2-aminopropanamido)-5-oxopentanoic acid; Glutamax I; L-Alany-L-glutamine; (2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoic acid; l-alanine-l-glutamine; Dipeptide Alanyl-Glutamine; UNII-U5JDO2770Z; AQ dipeptide; L-Alanyl-L-glutamine 1-hydrate; A-Q Dipeptide; N(2)-L-Alanine L-Glutamine dipeptide; Alanine Glutamine dipeptide; Alanine-Glutamine dipeptide; 210541-56-3; L-Ala-Gln, for cell culture; SCHEMBL133887; orb1301662; CHEMBL3707366; SCHEMBL29804717; GLUTAMINE, N2-L-ALANYL-; L-Alanyl-L-glutamine (Standard); Ala-Gln, 98% (TLC); ALANYL GLUTAMINE [WHO-DD]; BDBM627986; HY-W014102R; N(2)-L-ALANYL-LEVOGLUTAMIDE; (2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxo-pentanoic acid; s5801; AKOS010366801; CS-W014818; DB11876; FA29476; HY-W014102; L-ALANYL-L-GLUTAMINE [USP-RS]; CVD-0019434; L-Alanyl-L-glutamine, for cell culture; AS-12601; SY057432; DB-030066; A1261; NS00006426; ST51037125; BRD-K11595419-001-01-4; Q27144111; (2S)-2-((2S)-2-aminopropanoylamino)-4-carbamoylbutanoic acid; (S)-5-amino-2-((S)-2-aminopropanamido)-5-oxopentanoicacid; L-Alanyl-L-glutamine, United States Pharmacopeia (USP) Reference Standard; Ala-Gln, BioReagent, suitable for cell culture, suitable for insect cell culture",217.220,C8H15N3O4,